Skip to main content
. 2020 Apr 29;146(1):206–208.e2. doi: 10.1016/j.jaci.2020.04.029

Table I.

Clinical characteristics of patients with COVID-19 in intensive care unit

Clinical feature IFN-negative (n = 5) IFN-positive (n = 21) P value
Age (y), median (min-max) 81 (63-83) 74 (28-91) .696
Sex (male), n (%) 5 (100) 18 (86) 1.000
Delay between symptom onset and ICU admission (d) 7 (1-11) 7 (0-15) .769
Bacterial coinfection during ICU stay, n (%) 3 (60) 7 (33) .3402
Diabetes, n (%) 1 (20) 3 (14) .5043
Chronic obstructive pulmonary disease, n (%) 0 (0) 3 (14) 1.000
Cardiovascular disease, n (%) 2 (40) 9 (43) 1.000
Hypertension, n (%) 3 (60) 7 (33) .3402
Cancer, n (%) 1 (20) 3 (14) 1.000
Active smokers, n (%) 0 (0) 1(5) 1.000
BMI >30 kg/m2, n (%) 3 (60) 8 (38) .620
Biological feature, median (min-max)
 Viral load at diagnosis (Ct), median (min-max) 20.9 (18-28.2) 25.1 (16.1-38.0) .172
 Outcome, n (%)
 Standard oxygen therapy only 0 (0) 5 (24) .5451
 High flow oxygen therapy only 0 (0) 7 (33) .278
 Invasive ventilation at any time during ICU stay 5 (100) 9 (42) .0425
 ICU length of stay, median (min-max) 20 (7-30) 5 (0-35) .0503
 Mortality at day 28 after symptom onset, n (%) 2 (40) 8 (38) 1.000

P values were calculated using Mann-Whitney test for quantitative values and using Fisher-exact test for qualitative ones.

Statistical significance is defined by P < .05 (boldface).

BMI, Body mass index; ICU, intensive care unit.